VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BYAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BYAHPark Ha Biological Technology Co., Ltd. Ordinary Shares
$0.75$28M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

BYAH logoPark Ha Biological Technology Co., Ltd. Ordinary Shares(BYAH)Earnings, Financials & Key Ratios

BYAH•NASDAQ
$0.75
41.0× P/E·Price updated Jul 7, 2026
SectorConsumer CyclicalIndustryPersonal ServicesSub-IndustryBeauty Services and Personal Care Brands
AboutThe company is an investment holding company that develops skincare products under the “Park Ha” brand in the People’s Republic of China, through its subsidiaries operating in direct product sales and franchise services.Show more
  • Revenue$2M-3.1%
  • EBITDA$816K-32.0%
  • Net Income$479K-43.8%
  • EPS (Diluted)0.02-43.7%
  • Gross Margin91.8%+5.1%
  • EBITDA Margin34.28%-29.8%
  • Operating Margin33.32%-30.6%
  • Net Margin20.09%-42.0%
  • ROE38%-74.1%

BYAH Price & Volume

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock price & volume — 10-year historical chart

Loading chart...

Elite Gross Margins Mask Revenue Contraction Risks

Investment Thesis • Updated N/A

VerdictNeutral
Growth:Contracting
Profitability:Strong
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Geopolitical and Regulatory Exposure

Key Thesis Takeaways

  • Park Ha Biological Technology exhibits a bifurcated profile characterized by exceptional 91.80% gross margins alongside a concerning 3.14% year-over-year revenue decline, suggesting that its franchise-based distribution model is struggling with market saturation.
  • While the company maintains a pristine balance sheet with a negligible 0.05% debt-to-equity ratio, the lack of transparent cash flow data obscures the true quality of its 20.09% net margin.
  • Investors should monitor the sustainability of these premium margins against the backdrop of significant geopolitical and regulatory exposure inherent in its Chinese operational structure.

Verdict Logic

while the company reports a strong 20.09% net margin, the high 51.11x EV/EBITDA valuation combined with opaque cash flow reporting warrants a cautious wait-and-see approach.

BYAH Growth Metrics

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years36.77%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years131.34%
5 Years131.34%
3 Years131.34%
Last Year61.51%

Latest BYAH News

Recent stock market news and headlines for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

GlobeNewsWire·1 day ago
Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization

Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed. This successful entry represents a critical milestone in the execution of the Company's global expansion strategy, reflecting the Amazon platform's authoritative recognition of Park Ha Biological's overall brand strength, core product competitiveness, and standardized operational excellence.

Globe News Wire·1 day ago
Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization

Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co. , Ltd. (NASDAQ: BYAH) ("Park Ha Biological" or the "Company") announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed.

GlobeNewsWire·6 days ago
Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America

Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC).

Globe News Wire·Jun 29, 2026
Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy

Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co. , Ltd. (NASDAQ: BYAH) ("Park Ha Biological" or the "Company") announced significant progress in its global expansion by initiating cooperation with Amazon ("Amazon") North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business.

GlobeNewsWire·Jun 29, 2026
Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy

Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced significant progress in its global expansion by initiating cooperation with Amazon (“Amazon”) North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory efforts are being executed efficiently and systematically, with overall progress advancing ahead of schedule. This signifies that Park Ha Biological's online commercialization strategy in North America has entered a substantive implementation phase, laying a solid foundation for the launch of its flagship stores and sustained overseas operations.

Peers Comparison

Key metrics vs top competitors for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
BYAH logoBYAHPark Ha Biological Technology Co., Ltd. Ordinary SharesCurrent
$0.75$27.52M40.98-3.14%20.09%38%—
CLPS logoCLPSCLPS Incorporation
$0.84$24.98M-3.2315.17%-3.05%-15.02%—
CNET logoCNETZW Data Action Technologies Inc.
$0.99$3.22M-1.47-70.11%-33.27%-28.25%—
RETO logoRETOReTo Eco-Solutions, Inc.
$2.89$5.45M-1.1284.3%-397.95%-80.63%—
AGRI logoAGRIAgriFORCE Growing Systems Ltd.
$0.77$311.84K-0.02-100%-3666.64%-91.85%—
BTBT logoBTBTBit Digital, Inc.
$1.65$537.3M-5.32-30.65%-146.01%-0.11%—

Compare BYAH vs Peers

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CLPS

Most directly comparable listed peer for BYAH.

Scale Benchmark

vs NVAX

Larger-name benchmark to compare BYAH against a more recognizable public peer.

Peer Set

Compare Top 5

vs CLPS, CNET, RETO, AGRI

Get notified when BYAH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

BYAH Frequently Asked Questions

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Park Ha Biological Technology Co., Ltd. Ordinary Shares's revenue?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reported $2.4M in revenue for fiscal year 2024. This represents a 156% increase from $0.9M in 2021.

How fast is Park Ha Biological Technology Co., Ltd. Ordinary Shares growing?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) saw revenue decline by 3.1% over the past year.

Is BYAH profitable?

Yes, Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) is profitable, generating $0.5M in net income for fiscal year 2024 (20.1% net margin).

Dividend & Returns
What is BYAH's return on equity?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) has a return on equity (ROE) of 38.0%. This is excellent, indicating efficient use of shareholder capital.

What is Park Ha Biological Technology Co., Ltd. Ordinary Shares's free cash flow?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) generated $0.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in BYAH back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →